SunLink Health Systems, Inc. Announces Extension of Tender Offer to Repurchase up to 3,000,000 of Its Common Shares at a Pric...
February 09 2017 - 8:30AM
Business Wire
SunLink Health Systems, Inc. (NYSE MKT: SSY) announced today
that it has extended its previously announced tender offer to
purchase up to 3,000,000 of its common shares at a price of $1.50
per share (the “Offer”) until 5:00 p.m., New York City time, on
Friday, February 24, 2017, unless further extended or
terminated by SunLink. Tenders of shares must be made on or prior
to the expiration of the Offer and may be withdrawn at any time on
or prior to the expiration of the Offer. The tender offer to
purchase common shares was previously scheduled to expire at 5:00
p.m., New York City time, on February 8, 2017. As of 5:00 p.m.
Eastern time on February 8, 2017, 1,036,239 common shares have been
tendered and not withdrawn. Holders of common shares who have
already tendered their shares do not have to re-tender their
securities or take any other action as a result of the extension of
the expiration date of the Offer.
Complete terms and conditions of the Offer are set forth in the
Offer to Purchase, Letter of Transmittal and other related
materials that were filed as exhibits to the Tender Offer Statement
on Schedule TO filed by SunLink Health Systems, Inc. with the
Securities and Exchange Commission (the “SEC”) on January 10, 2017,
as amended and supplemented by Amendment No. 1 to such Schedule TO
filed with the SEC on February 3, 2017. Holders of common shares
wishing to participate in the tender offer should follow the
procedures set forth in the Company's offer to purchase dated
January 10, 2017 (the “Offer to Purchase”) and the related letter
of transmittal (the “Letter of Transmittal”) (the Offer to Purchase
and the Letter of Transmittal together, as they have been or may be
further amended or supplemented from time to time, the “Offer”.
The Information Agent for the Offer is D. F. King & Co.,
Inc. The Depositary is American Stock Transfer & Trust Company,
L.L.C. The Offer to Purchase, Letter of Transmittal and related
documents have been distributed or made available to shareholders
of record and also will be made available for distribution to
beneficial owners of SunLink common shares. For questions and
information, please call the Information Agent toll free at (212)
493-3910 (collect) if you are a bank or brokerage firm or otherwise
at (800) 966-9021 (toll-free).
Additional Information
This press release is provided for informational purposes
only and does not constitute an offer to purchase or the
solicitation of an offer to sell any common shares of SunLink
Health Systems, Inc. (“SunLink” or the “Company”). The tender offer
is being made only pursuant to the offer to purchase, letter of
transmittal, and related materials, as amended and supplemented,
pursuant to a tender offer statement on Schedule TO and Schedule
13E-3, as amended or supplemented, as filed with the SEC and
forming a part thereof. Investors and shareholders should read
those filings carefully as they contain important information about
the tender offer. Those documents as well as SunLink’s other public
filings with the SEC may be obtained without charge at the SEC’s
website at www.sec.gov and at SunLink’s website
at www.sunlinkhealth.com. The website addresses of
the SEC and SunLink are included in this press release for
reference only. The information contained on these websites is not
incorporated by reference in this press release and should not be
considered to be a part of this press release. The offer to
purchase and related materials may also be obtained without charge
by contacting D.F. King & Co., Inc., the Information Agent for
the Offer, at (212) 493-3910 (collect) if you are a bank or
brokerage firm or otherwise at (800) 966-9021 (toll-free).
All statements contained in this press release, other than
statements of historical fact, are forward-looking statements
including those regarding the expected timing of the tender offer
described in this press release. These statements speak only as of
the date of this press release and are based on our current plans
and expectations and involve risks and uncertainties that could
cause actual future events or results to be different from those
described in or implied by such forward-looking statements,
including risks and uncertainties regarding: changes in financial
markets; changes in economic, political or regulatory conditions or
other trends affecting the healthcare industry; and changes in
facts and circumstances and other uncertainties concerning the
completion of the tender offer. Further information about these
matters can be found in our Securities and Exchange Commission
filings. Except as required by applicable law or regulation, we do
not undertake any obligation to update our forward-looking
statements to reflect future events or circumstances.
SunLink Health Systems, Inc. is the parent company of
subsidiaries that own and operate healthcare businesses in the
Southeast. Each of the Company’s healthcare businesses is operated
locally with a strategy of linking patients’ needs with dedicated
physicians and healthcare professionals. For additional information
on SunLink Health Systems, Inc., please visit the Company’s
website.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170209005663/en/
SunLink Health Systems, Inc.Robert M. Thornton, Jr.,
770-933-7004Chief Executive Officer
Sunlink Health Systems (AMEX:SSY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sunlink Health Systems (AMEX:SSY)
Historical Stock Chart
From Apr 2023 to Apr 2024